PostEra
Healthcare AI
AI drug discovery / medicinal chemistry
Private
PostEra is an AI-first biotech company focused on medicinal chemistry and preclinical drug discovery. Its core platform, Proton, uses machine learning to accelerate the design and development of small-molecule therapeutics, and the company also advances internal programs in women’s health and fertility while partnering with pharma companies on additional discovery programs.
Company Details
- Website
- postera.ai
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2019
- Funding
- Over $1B in AI partnerships; ~ $26M in venture funding; $68M NIH grant (reported)
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring